Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03695900 · ClinicalTrials.gov registry record · NA
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
A NA study of Apnea of Prematurity and Desaturation of Blood, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03695900: Completed NA study of Apnea of Prematurity and Desaturation of Blood, sponsored by University of Miami.
NCT03695900 is a NA study of Apnea of Prematurity and Desaturation of Blood that has completed, run by University of Miami. The registered enrollment target is 19 participants, below the 406-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03695900, a NA study of Apnea of Prematurity and Desaturation of Blood, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29 weeks gestational age (GA).
Primary Outcome
by frequency of central apnea
Conditions Studied
Interventions
- OTHER Targeting SpO2 at 93-95%
- OTHER Targeting SpO2 at 90-92%
Study Locations (1)
Florida
- Holtz Children's Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-11-08 |
| Phase | NA |
What the finished NCT03695900 record still lists
NCT03695900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 406-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Apnea of Prematurity appearing as the primary indexed condition, and to 2 interventions - of which Targeting SpO2 at 93-95% is the first listed.
NCT03695900 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03695900 about?
NCT03695900 is a clinical study titled "Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants". This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to t...
What is the current status of trial NCT03695900?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-11-01. Estimated completion is 2019-11-08.
What conditions does trial NCT03695900 study?
This clinical trial studies the following conditions: Apnea of Prematurity, Desaturation of Blood, Central Apnea, Periodic Breathing, Obstructive Apnea of Newborn.
What interventions are being tested in trial NCT03695900?
The interventions under investigation include: Targeting SpO2 at 93-95% (OTHER), Targeting SpO2 at 90-92% (OTHER).
Who is sponsoring clinical trial NCT03695900?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03695900 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Apnea of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
"Prapela® SVS Incubator Pad for Apnea of Prematurity
RECRUITING · NA
-
A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
COMPLETED · NA
-
Caffeine Use in the Management of Preterm Infants
ACTIVE NOT RECRUITING · Phase 2
-
Caffeine for Apnea of Prematurity (CAP)
COMPLETED · Phase 3
-
The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI